PROBE study

PROBE logo

Phase 3 of the PROBE (Australia) Study is now complete

Read more about Phase 3 in Australia

The PROBE (Patient Reported Outcomes Burdens and Experiences) Study 

How can HFA and haemophilia organisations around the world have access to good quality data about the treatment and health experiences of people with bleeding disorders?

The multi-national PROBE (Patient Reported Outcomes Burdens and Experiences) Study aims to do precisely that.

Haemophilia Foundation Australia has joined the PROBE investigation team to be part of this important international study on the impact of living with a bleeding disorder.


PROBE is a patient-focused research project led by a global team of patient and academic investigators, including Mark Skinner, former WFH President, and Assoc Prof Alfonso Iorio from McMaster University, Canada, who have worked closely with HFA on the Australian arm of the study. The research will support efforts to improve treatment and comprehensive care programs in Australia and other countries around the world.

In the future the PROBE study will cover the range of bleeding disorders. The initial stages of the survey (Phases 1, 2 and 3) are testing and implementing the research methodology in haemophilia and allow people with haemophilia to report their haemophilia severity, treatment history and the impact of haemophilia on their daily life.

This data will be used to analyse the perspectives of people with haemophilia on outcomes that affect their own life and care. It is particularly important data to have when HFA tries to understand what the issues are for our community, and will enable us to quantify and represent these issues in a robust and credible way to our Council and others, such as governments or treatment and service funding bodies.

For more information about PROBE, visit the PROBE study website.

Date last reviewed: 27 April 2021